Valuation: Prenetics Global Limited

Capitalization 11Cr 9.01Cr 8.4Cr 7.81Cr 14Cr 904.76Cr 16Cr 101.46Cr 38Cr 424.2Cr 39Cr 39Cr 1.56TCr P/E ratio 2025 *
-2.97x
P/E ratio 2026 * -7.98x
Enterprise value 11Cr 9.01Cr 8.4Cr 7.81Cr 14Cr 904.76Cr 16Cr 101.46Cr 38Cr 424.2Cr 39Cr 39Cr 1.56TCr EV / Sales 2025 *
1.16x
EV / Sales 2026 * 0.73x
Free-Float
78.6%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.68%
1 week+0.76%
Current month-6.64%
1 month-14.15%
3 months+84.88%
6 months+32.50%
Current year+37.07%
More quotes
1 week 7.64
Extreme 7.6384
8.65
1 month 7.58
Extreme 7.58
10.22
Current year 3.09
Extreme 3.0947
11.99
1 year 3.09
Extreme 3.0947
11.99
3 years 2.85
Extreme 2.85
65.25
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
More quotes
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 51 01/01/2014
Chief Executive Officer 46 01/01/2014
Director of Finance/CFO 40 01/01/2018
Director TitleAgeSince
Chairman 46 01/01/2014
Director/Board Member 37 -
Director/Board Member 45 18/05/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.68%+0.76%+39.21%-86.72% 11Cr
-2.53%-1.96%+7.00%+12.32% 984.88Cr
-0.25%+3.88%+44.19%-21.61% 273.92Cr
-5.72%-15.32%-4.18%-5.44% 189.68Cr
-0.19%-11.84%+146.34%+16.43% 159.51Cr
-1.69%+0.63%+49.88%-31.03% 107.89Cr
-1.50%+23.26%-72.26%-80.79% 78Cr
+1.10%-40.99%-34.52%-45.08% 66Cr
+2.02%-1.72%+110.31% - 49Cr
-4.18%-12.09%-73.33%-90.30% 36Cr
Average -1.30%-4.58%+21.26%-36.92% 195.52Cr
Weighted average by Cap. -2.00%-3.41%+21.56%-4.72%
See all sector performances

Financials

2025 *2026 *
Net sales 9.04Cr 7.76Cr 7.23Cr 6.72Cr 12Cr 778.56Cr 14Cr 87Cr 33Cr 365.03Cr 34Cr 33Cr 1.34TCr 14Cr 12Cr 12Cr 11Cr 20Cr 1.24TCr 22Cr 139.46Cr 53Cr 583.08Cr 54Cr 53Cr 2.14TCr
Net income -3.73Cr -3.2Cr -2.98Cr -2.77Cr -5.12Cr -321.24Cr -5.72Cr -36Cr -14Cr -150.61Cr -14Cr -14Cr -553.63Cr -1.6Cr -1.37Cr -1.28Cr -1.19Cr -2.2Cr -137.8Cr -2.45Cr -15Cr -5.83Cr -65Cr -6Cr -5.88Cr -237.48Cr
Net Debt - -
More financial data * Estimated data
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
285
More about the company
Date Price Change Volume
18/25/18 7.950 $ -1.36% 23,107
17/25/17 8.060 $ -4.28% 39,708
16/25/16 8.420 $ +2.06% 69,897
15/25/15 8.250 $ +2.48% 24,708
14/25/14 8.050 $ +2.03% 36,442

Delayed Quote Nasdaq, July 18, 2025 at 10:38 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.060USD
Average target price
14.00USD
Spread / Average Target
+73.70%
Consensus

Quarterly revenue - Rate of surprise